SYKEHUSAPOTEKENE I MIDT-NORGE HF

Operating

Forside - Sykehusapotekene i Midt-Norge HF

Vi kan legemidler! Vår kompetanse og nærhet til sykehusene gjør at du får effektiv og tilpasset hjelp og oppfølging.

Effektivt og rasjonelt salg av legemidler til alle som trenger det når de trenger det og uavhengig av alder, kjønn eller etnisk bakgrunn. Foretaket skal bidra til å sikre andre helseforetak i regionen en god legemiddelforsyning, bidra til å sikre befolkningen tilgang på spesialiserte legemidler og tilby farmasøytiske tjenester som kan bidra til rasjonell og sikker legemiddelbruk i helsetjenesten.

Spesialisthelsetjeneste.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: DH
Dag Helge Hårstad1962
Chairman of the board: TV
Turid Vollan Riset1976
Years since formation: 25 years; since Dec 19, 2001
Type: Other business enterprise in accordance with special legislation
VAT registered: Yes
Number of employees: 386

Financials

Total operating income 2025: 1,661,411,522; NOK
Annual total result 2025: -42,665,046; NOK
Total equity 2025: 172,976,708; NOK

Last update: Sep 14, 2026

Management

Management / administration

Name	Role	Shares
DH Dag Helge Hårstad 1962	Managing Director/CEO	-

Board

Name	Role	Shares
TV Turid Vollan Riset 1976	Chairman	-
OS Olav Spigset 1963	Board Member	-
GF Gunn Fredriksen 1961	Deputy Chair	-
HS Hilde Severinsen 1970	Alternate Member	-
SA Steinar Abrahamsen 1969	Board Member	-
JK Jannicke Koppen Andresen 1979	Board Member	-
KL Kristin Langørgen Midttun 1968	Board Member	-
HM Hanne Mathilde Frøyshov 1967	Board Member	-
HK Hans Kristian Herskedal 1972	Board Member	-
HJ Heidi Johansen 1981	Alternate Member	-
MR Marte Rodum 1988	Alternate Member	-
ES Espen Skarstein Kolberg 1979	Alternate Member	-
MS Mikal Solstad Øiaas 1990	Alternate Member	-
JV Jesus Vaquero-Gomez 1988	Alternate Member	-
H HELSE MIDT-NORGE RHF	Health Enterprise	-

Others

Name	Role	Shares
B BDO AS	Auditor	-

Last update: Mar 10, 2026

Ownership

No available data

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	1,661,411,522	1,542,354,730	1,418,167,137	1,328,444,000	1,282,449,000
Annual Total Result	-42,665,046	2,451,002	19,443,762	13,740,000	22,485,000
Total assets	467,186,474	492,240,819	510,817,831	383,542,000	355,173,000
Total liabilities	294,209,766	276,599,069	297,627,084	189,796,000	175,167,000
Total equity	172,976,708	215,641,750	213,190,748	193,747,000	180,006,000

P&L

Year	2025	2024	2023	2022	2021
Total operating income	1,661,411,522	1,542,354,730	1,418,167,137	1,328,444,000	1,282,449,000
Total operating costs	1,706,731,777	1,550,222,050	1,406,087,172	1,319,353,000	1,260,498,000
Operating result	-45,320,255	-7,867,320	12,079,965	9,091,000	21,951,000
Financial income/costs	1,092,286	8,067,608	8,160,659	4,278,000	1,322,000
Profit before tax	-44,227,969	200,287	20,240,625	13,369,000	23,273,000
Total tax & extraordinary income/cost	-1,562,923	-2,250,715	796,863	-371,000	788,000
Annual Total Result	-42,665,046	2,451,002	19,443,762	13,740,000	22,485,000

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	278,747,091	238,033,684	106,313,956	68,496,000	64,109,000
Total current assets	188,439,383	254,207,134	404,503,875	315,046,000	291,064,000
Total assets	467,186,474	492,240,819	510,817,831	383,542,000	355,173,000
Short term debt	234,593,267	212,825,706	276,976,280	168,936,000	158,148,000
Long term debt	59,616,499	63,773,363	20,650,804	20,860,000	17,020,000
Total liabilities	294,209,766	276,599,069	297,627,084	189,796,000	175,167,000
Contributed capital	21,911,402	21,911,402	21,911,402	21,911,000	21,911,000
Retained earnings	151,065,306	193,730,348	191,279,345	171,836,000	158,094,000
Total equity	172,976,708	215,641,750	213,190,748	193,747,000	180,006,000
Total equity and liabilities	467,186,474	492,240,819	510,817,831	383,543,000	355,173,000

Classification

21st company classification

BETA

Industrial large enterprise

SYKEHUSAPOTEKENE I MIDT-NORGE HF983 974 805